86(top 5%)
PR articles
42.5K(top 0.1%)
PR citations
53(top 1%)
PR h-index
58(top 1%)
h-index
108
documents
56.6K
doc citations
4.6K
citing journals
100
times ranked

Publications

88 peer-reviewed articles • 45,941 peer-reviewed citations • Sorted by year • Download PDF (PDF by citations)
Sort: Year | Citations
#ArticleIFCitationsLinks
1RORγ Bridges Cancer-Driven Lipid Dysmetabolism and Myeloid Immunosuppression
Cancer Discovery, 2025, 15, 1505-1525
6.814Citations (PDF)
2Feline Leishmaniosis: A Retrospective Study of Seroprevalence in Cats in the Campania Region, Southern Italy
Animals, 2025, 15, 1801
1.75Citations (PDF)
3Immunosenescence, Inflammaging, and Frailty: Role of Myeloid Cells in Age-Related Diseases
Clinical Reviews in Allergy and Immunology, 2022, 64, 123-144
4.5150Citations (PDF)
4Evolution and Targeting of Myeloid Suppressor Cells in Cancer: A Translational Perspective
Cancers, 2022, 14, 510
2.714Citations (PDF)
5Inflammaging and Osteoarthritis
Clinical Reviews in Allergy and Immunology, 2022, 64, 222-238
4.5381Citations (PDF)
6Precision Medicine Approaches with Metabolomics and Artificial Intelligence
International Journal of Molecular Sciences, 2022, 23, 11269
3.257Citations (PDF)
7Heme catabolism by tumor-associated macrophages controls metastasis formation
Nature Immunology, 2021, 22, 595-606
14.1119Citations (PDF)
8Regulation of PD-L1 Expression by NF-κB in Cancer
Frontiers in Immunology, 2020, 11,
3.3376Citations (PDF)
9Frailty in Rheumatic Diseases
Frontiers in Immunology, 2020, 11,
3.379Citations (PDF)
10Immunometabolic Status of COVID-19 Cancer Patients
Physiological Reviews, 2020, 100, 1839-1850
20.133Citations (PDF)
11The Macrophages-Microbiota Interplay in Colorectal Cancer (CRC)-Related Inflammation: Prognostic and Therapeutic Significance
International Journal of Molecular Sciences, 2020, 21, 6866
3.246Citations (PDF)
12Lipid Metabolism and Cancer Immunotherapy: Immunosuppressive Myeloid Cells at the Crossroad
International Journal of Molecular Sciences, 2020, 21, 5845
3.287Citations (PDF)
13Influence of Innate Immunity on Cancer Cell Stemness
International Journal of Molecular Sciences, 2020, 21, 3352
3.227Citations (PDF)
14Melanoma-specific bcl-2 promotes a protumoral M2-like phenotype by tumor-associated macrophages
2020, 8, e000489
45Citations (PDF)
15Tumor-Derived Prostaglandin E2 Promotes p50 NF-κB-Dependent Differentiation of Monocytic MDSCs
Cancer Research, 2020, 80, 2874-2888
2.6126Citations (PDF)
16Implications of metabolism-driven myeloid dysfunctions in cancer therapy
Cellular and Molecular Immunology, 2020, 18, 829-841
10.035Citations (PDF)
17A Proteomic Analysis of GSD-1a in Mouse Livers: Evidence for Metabolic Reprogramming, Inflammation, and Macrophage Polarization
Journal of Proteome Research, 2019, 18, 2965-2978
2.215Citations (PDF)
18Myeloid-Derived Suppressor Cells: Ductile Targets in Disease
Frontiers in Immunology, 2019, 10,
3.3101Citations (PDF)
19Modulation of peripheral blood immune cells by early use of steroids and its association with clinical outcomes in patients with metastatic non-small cell lung cancer treated with immune checkpoint inhibitors
ESMO Open, 2019, 4, e000457
3.2202Citations (PDF)
20Choosing wisely first line immunotherapy in non-small cell lung cancer (NSCLC): what to add and what to leave out
Cancer Treatment Reviews, 2019, 75, 39-51
6.0148Citations (PDF)
21Nicotinamide Phosphoribosyltransferase Acts as a Metabolic Gate for Mobilization of Myeloid-Derived Suppressor Cells
Cancer Research, 2019, 79, 1938-1951
2.675Citations (PDF)
22Targeting Cancer Cells and Tumor Microenvironment in Preclinical and Clinical Models of Hodgkin Lymphoma Using the Dual PI3Kδ/γ Inhibitor RP6530
Clinical Cancer Research, 2019, 25, 1098-1112
4.584Citations (PDF)
23Myelopoiesis, metabolism and therapy: a crucial crossroads in cancer progression
Cell Stress, 2019, 3, 284-294
1.853Citations (PDF)
24Tumor‐associated myeloid cells: new understandings on their metabolic regulation and their influence in cancer immunotherapy
FEBS Journal, 2018, 285, 717-733
3.360Citations (PDF)
25Protumor Steering of Cancer Inflammation by p50 NF-κB Enhances Colorectal Cancer Progression
Cancer Immunology Research, 2018, 6, 578-593
3.154Citations (PDF)
26Metabolic influence on the differentiation of suppressive myeloid cells in cancer
Carcinogenesis, 2018, 39, 1095-1104
2.229Citations (PDF)
27Tumor-associated myeloid cells as guiding forces of cancer cell stemness
Cancer Immunology, Immunotherapy, 2017, 66, 1025-1036
3.145Citations (PDF)
28Metabolic regulation of suppressive myeloid cells in cancer
Cytokine and Growth Factor Reviews, 2017, 35, 27-35
7.338Citations (PDF)
29Inflammation as target in cancer therapy
Current Opinion in Pharmacology, 2017, 35, 57-65
2.8112Citations (PDF)
30Myeloid suppressor cells in cancer and autoimmunity
Journal of Autoimmunity, 2017, 85, 117-125
3.8181Citations (PDF)
31Cholangiocarcinoma stem-like subset shapes tumor-initiating niche by educating associated macrophages
Journal of Hepatology, 2017, 66, 102-115
6.7170Citations (PDF)
32Recommendations for myeloid-derived suppressor cell nomenclature and characterization standards
Nature Communications, 2016, 7,
10.82,685Citations (PDF)
33Macrophage polarization in pathology
Cellular and Molecular Life Sciences, 2015, 72, 4111-4126
3.5642Citations (PDF)
34RORC1 Regulates Tumor-Promoting “Emergency” Granulo-Monocytopoiesis
Cancer Cell, 2015, 28, 253-269
28.4189Citations (PDF)
35Molecular and epigenetic basis of macrophage polarized activation
Seminars in Immunology, 2015, 27, 237-248
5.7289Citations (PDF)
36Cancer stem cells and tumor-associated macrophages: a roadmap for multitargeting strategies
Oncogene, 2015, 35, 671-682
5.2138Citations (PDF)
37Macrophage Plasticity and Polarization in Liver Homeostasis and Pathology
Hepatology, 2014, 59, 2034-2042
9.6407Citations (PDF)
38Targeting Tumor-Associated Macrophages with Anti-CSF-1R Antibody Reveals a Strategy for Cancer Therapy
Cancer Cell, 2014, 25, 846-859
28.41,306Citations (PDF)
39Macrophage plasticity and polarization in tissue repair and remodelling
Journal of Pathology, 2013, 229, 176-185
3.22,279Citations (PDF)
40Hypoxia-mediated regulation of macrophage functions in pathophysiology
International Immunology, 2013, 25, 67-75
2.087Citations (PDF)
41miR-146a and NF-κB1 Regulate Mast Cell Survival and T Lymphocyte Differentiation
Molecular and Cellular Biology, 2012, 32, 4432-4444
1.562Citations (PDF)
42Macrophage plasticity and polarization: in vivo veritas
Journal of Clinical Investigation, 2012, 122, 787-795
6.65,916Citations (PDF)
43The p50 Subunit of NF-κB Orchestrates Dendritic Cell Lifespan and Activation of Adaptive Immunity
PLoS ONE, 2012, 7, e45279
1.520Citations (PDF)
44Macrophages in Cancer and Infectious Diseases: The ‘Good‘ and the ‘Bad‘
Immunotherapy, 2011, 3, 1185-1202
1.231Citations (PDF)
45Mechanisms linking pathogens-associated inflammation and cancer
Cancer Letters, 2011, 305, 250-262
6.5108Citations (PDF)
46Hypoxia: a double-edged sword of immunity
Journal of Molecular Medicine, 2011, 89, 657-665
2.859Citations (PDF)
47Origin and Functions of Tumor-Associated Myeloid Cells (TAMCs)
Cancer Microenvironment, 2011, 5, 133-149
5.694Citations (PDF)
48Macrophages, innate immunity and cancer: balance, tolerance, and diversity
Current Opinion in Immunology, 2010, 22, 231-237
3.71,384Citations (PDF)
49Tolerance and M2 (alternative) macrophage polarization are related processes orchestrated by p50 nuclear factor κB
Proceedings of the National Academy of Sciences of the United States of America, 2009, 106, 14978-14983
5.2618Citations (PDF)
50Cellular and molecular pathways linking inflammation and cancer
Immunobiology, 2009, 214, 761-777
0.9246Citations (PDF)
51Tumor-associated macrophages and the related myeloid-derived suppressor cells as a paradigm of the diversity of macrophage activation
Human Immunology, 2009, 70, 325-330
0.5313Citations (PDF)
52Cancer-related inflammation, the seventh hallmark of cancer: links to genetic instability
Carcinogenesis, 2009, 30, 1073-1081
2.22,644Citations (PDF)
53Angiostatin anti-angiogenesis requires IL-12: The innate immune system as a key target
Journal of Translational Medicine, 2009, 7,
4.847Citations (PDF)
54A distinguishing gene signature shared by tumor-infiltrating Tie2-expressing monocytes, blood “resident” monocytes, and embryonic macrophages suggests common functions and developmental relationships
Blood, 2009, 114, 901-914
3.6321Citations (PDF)
55The inflammatory micro-environment in tumor progression: The role of tumor-associated macrophages
Critical Reviews in Oncology/Hematology, 2008, 66, 1-9
3.5950Citations (PDF)
56Cancer-related inflammation
Nature, 2008, 454, 436-444
30.710,844Citations (PDF)
57Macrophage polarization in tumour progression
Seminars in Cancer Biology, 2008, 18, 349-355
10.51,142Citations (PDF)
58Cancer related inflammation: The macrophage connection
Cancer Letters, 2008, 267, 204-215
6.5544Citations (PDF)
59Pathways connecting inflammation and cancer
Current Opinion in Genetics and Development, 2008, 18, 3-10
2.4394Citations (PDF)
60Macrophage activation and polarization
Frontiers in Bioscience - Landmark, 2008, 13, 453
5.82,848Citations (PDF)
61Targeting tumour-associated macrophages
Expert Opinion on Therapeutic Targets, 2007, 11, 1219-1229
2.856Citations (PDF)
62Altered macrophage differentiation and immune dysfunction in tumor development
Journal of Clinical Investigation, 2007, 117, 1155-1166
6.61,112Citations (PDF)
63Tumor-associated macrophages (TAMs) as new target in anticancer therapy
Drug Discovery Today: Therapeutic Strategies, 2006, 3, 361-366
0.313Citations (PDF)
64Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: Potential targets of anti-cancer therapy
European Journal of Cancer, 2006, 42, 717-727
2.81,374Citations (PDF)
65A distinct and unique transcriptional program expressed by tumor-associated macrophages (defective NF- B and enhanced IRF-3/STAT1 activation)
Blood, 2006, 107, 2112-2122
3.6657Citations (PDF)
66Role of tumor-associated macrophages in tumor progression and invasion
Cancer and Metastasis Reviews, 2006, 25, 315-322
6.8857Citations (PDF)
67Epidermal Growth Factor and Hypoxia-induced Expression of CXC Chemokine Receptor 4 on Non-small Cell Lung Cancer Cells Is Regulated by the Phosphatidylinositol 3-Kinase/PTEN/AKT/Mammalian Target of Rapamycin Signaling Pathway and Activation of Hypoxia Inducible Factor-1α
Journal of Biological Chemistry, 2005, 280, 22473-22481
1.3302Citations (PDF)
68Chemokines in the recruitment and shaping of the leukocyte infiltrate of tumors
Seminars in Cancer Biology, 2004, 14, 155-160
10.5192Citations (PDF)
69Tumour-associated macrophages as a prototypic type II polarised phagocyte population: role in tumour progression
European Journal of Cancer, 2004, 40, 1660-1667
2.8313Citations (PDF)
70The chemokine system in diverse forms of macrophage activation and polarization
Trends in Immunology, 2004, 25, 677-686
5.76,089Citations (PDF)
71Response to Hellstrand: The jury on radicals is still out
Trends in Immunology, 2003, 24, 234
5.73Citations (PDF)
72Regulation of the Chemokine Receptor CXCR4 by Hypoxia
Journal of Experimental Medicine, 2003, 198, 1391-1402
5.9819Citations (PDF)
73Tumor-Associated Macrophages and Dendritic Cells as Prototypic Type II Polarized Myeloid Populations
Tumori, 2003, 89, 459-468
1.159Citations (PDF)
74Glutathione Protects Mice from Lethal Sepsis by Limiting Inflammation and Potentiating Host Defense
Journal of Infectious Diseases, 2002, 185, 1115-1120
2.281Citations (PDF)
75Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes
Trends in Immunology, 2002, 23, 549-555
5.75,164Citations (PDF)
76Tumor-associated macrophages: a molecular perspective
International Immunopharmacology, 2002, 2, 1045-1054
3.0110Citations (PDF)
77The chemokine receptor switch paradigm and dendritic cell migration: its significance in tumor tissues
Immunological Reviews, 2000, 177, 141-149
5.8147Citations (PDF)
78Redox regulation of chemokine receptor expression
Proceedings of the National Academy of Sciences of the United States of America, 2000, 97, 2761-2766
5.2115Citations (PDF)
79MCP-1 and CCR2 in HIV infection: regulation of agonist and receptor expression
Journal of Leukocyte Biology, 1997, 62, 30-33
1.762Citations (PDF)
80Characterization of the Promoter for the Human Long Pentraxin PTX3
Journal of Biological Chemistry, 1997, 272, 8172-8178
1.3155Citations (PDF)
81LPS-inducible nuclear factor in human monocytes that binds the negative regulatory element of the HIV LTR
Journal of Leukocyte Biology, 1994, 56, 21-26
1.76Citations (PDF)
82Nonsense mutations affect C1 inhibitor messenger RNA levels in patients with type I hereditary angioneurotic edema.
Journal of Clinical Investigation, 1991, 88, 755-759
6.633Citations (PDF)
83A chemoattractant expressed in human sarcoma cells (tumor-derived chemotactic factor, TDCF) is identical to monocyte chemoattractant protein-1/monocyte chemotactic and activating factor (MCP-1/MCAF)
International Journal of Cancer, 1990, 45, 795-797
2.888Citations (PDF)
84Interleukin-6 gene expression and production induced in human monocytes by membrane proteoglycans from Klebsiella pneumoniae
International Journal of Immunopharmacology, 1990, 12, 397-402
1.314Citations (PDF)
85Propafenone and 5-hydroxypropafenone concentrations in the right atrium of patients undergoing heart surgery
American Heart Journal, 1989, 117, 497-498
1.87Citations (PDF)
86High-performance liquid chromatographic separation and mass spectrometric identification of propafenone, 5-hydroxypropafenone and N-depropylpropafenone
Biomedical Applications, 1988, 424, 211-214
1.912Citations (PDF)
87Oncolytic virotherapy: new weapon for breast cancer treatment
Ecancermedicalscience, 0, 14,
0.928Citations (PDF)
88Title is missing!
0
1Citations (PDF)